Skip to Content

Virtual Diagnosis?

September 1, 2000

The AIDS virus’s ability to quickly mutate and become resistant to new drugs makes it difficult for doctors to choose medications that will work. Researchers at Virco Group in Oxford, England, have created a new tool to give doctors better information about viral drug resistance, allowing them to design effective therapies. Called Virtual Phenotype, the analysis takes the genetic code of a patient’s HIV strain and predicts the drugs it will be resistant to. The system, one of the earliest examples of pharmacogenomics in action, reportedly provides the first quantitative analysis of viral drug resistance. The analysis is quicker than actual phenotype testing, which involves growing virus and screening it with drugs, and costs up to three times less. Virco is developing similar databases for cancer and hepatitis B.

Keep Reading

Most Popular

10 Breakthrough Technologies 2024

Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

AI for everything: 10 Breakthrough Technologies 2024

Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.

What’s next for AI in 2024

Our writers look at the four hot trends to watch out for this year

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.